Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MedAdvisor Limited (AHE) vs. Competitors

19 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:AHEMedAdvisor LimitedAUD 0.01AUD 8.29M-0.42-43.48%―Unlock the AU:AHE analyst price target with TipRanks PremiumAU:AHEUnlock the AU:AHE top-analyst price target with TipRanks Premium
AU:ONEOneview Healthcare Chess Depository Interests repr 1AUD 0.12AUD 100.70M-5.74-55.56%Moderate BuyUnlock the AU:ONE analyst price target with TipRanks PremiumAU:AHE vs AU:ONEUnlock the AU:ONE top-analyst price target with TipRanks Premium
AU:PHXPharmX TechnologiesAUD 0.07AUD 46.13M-17.58-48.89%Moderate BuyUnlock the AU:PHX analyst price target with TipRanks PremiumAU:AHE vs AU:PHXUnlock the AU:PHX top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 1.25AUD 168.73M70.5913.64%Strong BuyUnlock the AU:ALC analyst price target with TipRanks PremiumAU:AHE vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium
AU:ICRInteliCare Holdings LimitedAUD 0.02AUD 12.16M-5.00-34.62%―Unlock the AU:ICR analyst price target with TipRanks PremiumAU:AHE vs AU:ICRUnlock the AU:ICR top-analyst price target with TipRanks Premium
AU:PCKPainChek LtdAUD 0.07AUD 14.23M-1.57-83.81%―Unlock the AU:PCK analyst price target with TipRanks PremiumAU:AHE vs AU:PCKUnlock the AU:PCK top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:AHEMedAdvisor Limited0.01-0.01-43.48%
AU:ONEOneview Healthcare Chess Depository Interests repr 10.12-0.15-54.72%
AU:PHXPharmX Technologies0.07-0.07-50.71%
AU:ALCAlcidion Group Limited1.250.1513.64%
AU:ICRInteliCare Holdings Limited0.02-0.01-41.38%
AU:PCKPainChek Ltd0.07-0.36-84.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts